Results from nationwide hepatitis B serosurvey in Cambodia using simple and rapid laboratory test: implications for

Sann Chan Soeung1, Manju Rani, Vu Huong

  • 1Ministry of Health Cambodia, Phnom Penh, Cambodia. sann_chansoeung@yahoo.com

Insights

Hepatitis B infection is high in Cambodia. This study found 3.5% of five-year-olds have the virus, highlighting the need for vaccination to control chronic liver disease.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Hepatology

Background:

  • Chronic hepatitis B infection and liver cancer are significant health burdens in the Western Pacific region.
  • Cambodia faces a disproportionate impact of these diseases relative to its population size.

Purpose of the Study:

  • To provide the first nationwide estimates of hepatitis B surface antigen (HBsAg) seroprevalence in Cambodian children aged five years.
  • To assess the feasibility of using rapid diagnostic tests for nationwide serosurveys to evaluate hepatitis B control programs.

Main Methods:

  • Employed a multi-stage stratified cluster sampling design for nationwide data collection.
  • Utilized a simple and rapid test for detecting HBsAg in the target population.

Main Results:

  • Estimated HBsAg seroprevalence to be 3.5% (95% CI: 2.4-4.8%) among five-year-old children in Cambodia.
  • Demonstrated the effectiveness of rapid tests in conducting nationwide serosurveys, offering an alternative to standard enzyme-linked immunosorbent assays.

Conclusions:

  • Interrupting perinatal transmission and implementing catch-up vaccination are crucial for hepatitis B control in Cambodia.
  • Achieving a chronic infection rate below 2% in children aged five years and older is attainable with targeted interventions.